Table of Contents Author Guidelines Submit a Manuscript
Computational and Mathematical Methods in Medicine
Volume 2019, Article ID 9783986, 26 pages
https://doi.org/10.1155/2019/9783986
Research Article

Multiple-Strain Malaria Infection and Its Impacts on Plasmodium falciparum Resistance to Antimalarial Therapy: A Mathematical Modelling Perspective

Institute of Mathematical Sciences, Strathmore University, P.O. Box 59857-00200, Nairobi, Kenya

Correspondence should be addressed to Titus Okello Orwa; ude.eromhtarts@awrot

Received 14 February 2019; Accepted 15 May 2019; Published 11 June 2019

Academic Editor: Konstantin Blyuss

Copyright © 2019 Titus Okello Orwa et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. M. Dondorp, S. Yeung, L. White et al., “Artemisinin resistance: current status and scenarios for containment,” Nature Reviews Microbiology, vol. 8, no. 4, pp. 272–280, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. R. J. Maude, W. Pontavornpinyo, S. Saralamba et al., “The last man standing is the most resistant: eliminating artemisinin-resistant malaria in Cambodia,” Malaria Journal, vol. 8, no. 1, p. 31, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. A. B. S. Sidhu, D. Verdier-Pinard, and D. A. Fidock, “Chloroquine resistance in plasmodium falciparum malaria parasites conferred by pfcrt mutations,” Science, vol. 298, no. 5591, pp. 210–213, 2002. View at Publisher · View at Google Scholar · View at Scopus
  4. T. E. Wellems and C. V. Plowe, “Chloroquine—resistant malaria,” Journal of Infectious Diseases, vol. 184, no. 6, pp. 770–776, 2001. View at Publisher · View at Google Scholar · View at Scopus
  5. D. L. Smith, E. Y. Klein, F. E. McKenzie, and R. Laxminarayan, “Prospective strategies to delay the evolution of anti-malarial drug resistance: weighing the uncertainty,” Malaria Journal, vol. 9, no. 217, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. R. W. Snow, J.-F. Trape, and K. Marsh, “The past, present and future of childhood malaria mortality in africa,” TRENDS in Parasitology, vol. 17, no. 12, pp. 593–597, 2001. View at Publisher · View at Google Scholar · View at Scopus
  7. N. J. White, “Delaying antimalarial drug resistance with combination chemotherapy,” Parassitologia, vol. 41, no. 1–3, pp. 301–308, 1999. View at Google Scholar
  8. WHO, A Global Strategy for Malaria Control, World Health Organization, Geneva, Switzerland, 1993.
  9. Y. Kim and K. A. Schneider, “Evolution of drug resistance in malaria parasite populations,” Nature Education Knowledge, vol. 4, no. 8, pp. 6–16, 2013. View at Google Scholar
  10. A. O. Talisuna, P. Bloland, and U. D’Alessandro, “History, dynamics, and public health importance of malaria parasite resistance,” Clinical Microbiology Reviews, vol. 17, no. 1, pp. 235–254, 2004. View at Publisher · View at Google Scholar · View at Scopus
  11. N. J. White and W. Pongtavornpinyo, “The de novo selection of drug-resistant malaria parasites,” Proceedings of the Royal Society of London. Series B: Biological Sciences, vol. 270, no. 1514, pp. 545–554, 2003. View at Publisher · View at Google Scholar · View at Scopus
  12. J.-F. Trape, G. Pison, M.-P. Preziosi et al., “Impact of chloroquine resistance on malaria mortality,” Comptes Rendus de l’Académie des Sciences—Series III—Sciences de la Vie, vol. 321, no. 8, pp. 689–697, 1998. View at Publisher · View at Google Scholar · View at Scopus
  13. WHO, Guidelines for the Treatment of Malaria, World Health Organization, Geneva, Switzerland, 2018.
  14. J. K. Baird, M. F. S. Nalim, H. Basri et al., “Survey of resistance to chloroquine by plasmodium vivax in Indonesia,” Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 90, no. 4, pp. 409–411, 1996. View at Publisher · View at Google Scholar · View at Scopus
  15. P. E. Thompson and W. Leslie, “Antimalarial agents: chemistry and phamacology,” in Medicinal Chemistry, G. de Stevens, Ed., Academic Press, New York, NY, USA, 1972. View at Google Scholar
  16. T. Harinasuta, P. Suntharasamai, and C. Viravan, “Chloroquine-resistant falciparum malaria in Thailand,” The Lancet, vol. 286, no. 7414, pp. 657–660, 1965. View at Publisher · View at Google Scholar · View at Scopus
  17. S. Fogh, S. Jepsen, and P. Effersøe, “Chloroquine-resistant plasmodium falciparum malaria in Kenya,” Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 73, no. 2, pp. 228-229, 1979. View at Publisher · View at Google Scholar · View at Scopus
  18. E. Onori, “The problem of plasmodium falciparum drug resistance in africa south of the sahara,” Bulletin of the World Health Organization, vol. 62, pp. 55–62, 1984. View at Google Scholar
  19. J. M. Ekue, A. M. Ulrich, and E. K. Njelesani, “Plasmodium malaria resistant to chloroquine in a Zambian living in Zambia,” BMJ, vol. 286, no. 6374, pp. 1315-1316, 1983. View at Publisher · View at Google Scholar
  20. D. Overbosch, A. W. van den Wall Bake, P. C Stuiver, and H. J van der Kaay, “Chloroquine-resistant falciparum malaria from Malawi,” Tropical and Geographical Medicine, vol. 36, no. 1, pp. 71-72, 1984. View at Google Scholar
  21. W. H. Wernsdorfer and D. Payne, “The dynamics of drug resistance in plasmodium falciparum,” Pharmacology & Therapeutics, vol. 50, no. 1, pp. 95–121, 1991. View at Google Scholar
  22. B. L. Bredenkamp, B. L. Sharp, S. D. Mthembu, D. N. Durrheim, and K. I. Barnes, “Failure of sulphadoxine-pyrimethamine in treating plasmodium falciparum malaria in KwaZulu-Natal,” South African Medical Journal=Suid-Afrikaanse tydskrif vir geneeskunde, vol. 91, no. 11, pp. 970–972, 2001. View at Google Scholar
  23. P. B. Bloland, E. M. Lackritz, P. N. Kazembe, J. B. O. Were, R. Steketee, and C. C. Campbell, “Beyond chloroquine: implications of drug resistance for evaluating malaria therapy efficacy and treatment policy in africa,” Journal of Infectious Diseases, vol. 167, no. 4, pp. 932–937, 1993. View at Publisher · View at Google Scholar · View at Scopus
  24. S. J. Foote and A. F. Cowman, “The mode of action and the mechanism of resistance to antimalarial drugs,” Acta Tropica, vol. 56, no. 2-3, pp. 157–171, 1994. View at Publisher · View at Google Scholar · View at Scopus
  25. WHO, Artemisinin and Artemisinin-Based Combination Therapy Resistance. Global Malaria Programme, World Health Organization, Geneva, Switzerland, 2016.
  26. WHO, Q & A on Artemisinin Resistance, World Health Organization, Geneva, Switzerland, 2018.
  27. M. Bushman, L. Morton, N. Duah et al., “Within-host competition and drug resistance in the human malaria parasite plasmodium falciparum,” Proceedings of the Royal Society B: Biological Sciences, vol. 283, no. 1826, Article ID 20153038, 2016. View at Publisher · View at Google Scholar · View at Scopus
  28. W. E. Harrington, T. K. Mutabingwa, A. Muehlenbachs et al., “Competitive facilitation of drug-resistant plasmodium falciparum malaria parasites in pregnant women who receive preventive treatment,” Proceedings of the National Academy of Sciences, vol. 106, no. 22, pp. 9027–9032, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. M. Bushman, R. Antia, V. Udhayakumar, and J. C. de Roode, “Within-host competition can delay evolution of drug resistance in malaria,” PLoS biology, vol. 16, no. 8, 2018. View at Publisher · View at Google Scholar · View at Scopus
  30. T. Mita, K. Tanabe, and K. Kita, “Spread and evolution of plasmodium falciparum drug resistance,” Parasitology International, vol. 58, no. 3, pp. 201–209, 2009. View at Publisher · View at Google Scholar · View at Scopus
  31. S. Vinayak, M. T. Alam, T. Mixson-Hayden et al., “Origin and evolution of sulfadoxine resistant plasmodium falciparum,” PLoS Pathogens, vol. 6, no. 3, Article ID e1000830, 2010. View at Publisher · View at Google Scholar · View at Scopus
  32. I. M. Hastings and W. M. Watkins, “Intensity of malaria transmission and the evolution of drug resistance,” Acta Tropica, vol. 94, no. 3, pp. 218–229, 2005. View at Publisher · View at Google Scholar · View at Scopus
  33. A. O. Talisuna, P. Langi, T. K. Mutabingwa et al., “Intensity of transmission and spread of gene mutations linked to chloroquine and sulphadoxine-pyrimethamine resistance in falciparum malaria,” International Journal for Parasitology, vol. 33, no. 10, pp. 1051–1058, 2003. View at Publisher · View at Google Scholar · View at Scopus
  34. E. Y. Klein, D. L. Smith, M. F. Boni, and R. Laxminarayan, “Clinically immune hosts as a refuge for drug-sensitive malaria parasites,” Malaria Journal, vol. 7, no. 67, 2008. View at Publisher · View at Google Scholar · View at Scopus
  35. WHO, World Malaria Report 2017, World Health Organization, Geneva, Switzerland, 2017.
  36. F. E. McKenzie, “Why model malaria?” Parasitology Today, vol. 16, no. 12, pp. 511–516, 2000. View at Publisher · View at Google Scholar · View at Scopus
  37. F. E. McKenzie and E. M. Samba, “The role of mathematical modeling in evidence-based malaria control,” American Journal of Tropical Medicine and Hygiene, vol. 71, pp. 94–96, 2004. View at Publisher · View at Google Scholar
  38. P. G. Coleman, S. Shillcutt, C. Morel, A. J. Mills, and C. Goodman, “A threshold analysis of the cost-effectiveness of artemisinin-based combination therapies in sub-Saharan Africa,” American Journal of Tropical Medicine and Hygiene, vol. 71, pp. 196–204, 2004. View at Publisher · View at Google Scholar
  39. I. M. Hastings, “A model for the origins and spread of drug-resistant malaria,” Parasitology, vol. 115, no. 2, pp. 133–141, 1997. View at Publisher · View at Google Scholar · View at Scopus
  40. M. J. Mackinnon, “Drug resistance models for malaria,” Acta Tropica, vol. 94, no. 3, pp. 207–217, 2005. View at Publisher · View at Google Scholar · View at Scopus
  41. S. J. Aneke, “Mathematical modelling of drug resistant malaria parasites and vector populations,” Mathematical Methods in the Applied Sciences, vol. 25, no. 4, pp. 335–346, 2002. View at Publisher · View at Google Scholar · View at Scopus
  42. J. Koella and R. Antia, “Epidemiological models for the spread of anti-malarial resistance,” Malaria Journal, vol. 2, no. 1, p. 3, 2003. View at Publisher · View at Google Scholar
  43. L. Esteva, A. B. Gumel, and C. V. De LeóN, “Qualitative study of transmission dynamics of drug-resistant malaria,” Mathematical and Computer Modelling, vol. 50, no. 3-4, pp. 611–630, 2009. View at Publisher · View at Google Scholar · View at Scopus
  44. E. Y. Klein, D. L. Smith, R. Laxminarayan, and S. Levin, “Superinfection and the evolution of resistance to antimalarial drugs,” Proceedings of the Royal Society B: Biological Sciences, vol. 279, no. 1743, pp. 3834–3842, 2012. View at Publisher · View at Google Scholar · View at Scopus
  45. M. Legros and S. Bonhoeffer, “A combined within-host and between-hosts modelling framework for the evolution of resistance to antimalarial drugs,” Journal of the Royal Society Interface, vol. 13, no. 117, Article ID 20160148, 2016. View at Publisher · View at Google Scholar · View at Scopus
  46. A. R. Wargo, S. Huijben, J. C. De Roode, J. Shepherd, and A. F. Read, “Competitive release and facilitation of drug-resistant parasites after therapeutic chemotherapy in a rodent malaria model,” Proceedings of the National Academy of Sciences, vol. 104, no. 50, pp. 19914–19919, 2007. View at Publisher · View at Google Scholar · View at Scopus
  47. P. A. zur Wiesch, R. Kouyos, J. Engelstädter, R. R. Regoes, and S. Bonhoeffer, “Population biological principles of drug-resistance evolution in infectious diseases,” The Lancet Infectious Diseases, vol. 11, no. 3, pp. 236–247, 2011. View at Publisher · View at Google Scholar · View at Scopus
  48. Z. Agur, D. Abiri, and L. H. Van der Ploeg, “Ordered appearance of antigenic variants of african trypanosomes explained in a mathematical model based on a stochastic switch process and immune-selection against putative switch intermediates,” Proceedings of the National Academy of Sciences, vol. 86, no. 23, pp. 9626–9630, 1989. View at Publisher · View at Google Scholar · View at Scopus
  49. R. Antia, B. R. Levin, and R. M. May, “Within-host population dynamics and the evolution and maintenance of microparasite virulence,” American Naturalist, vol. 144, no. 3, pp. 457–472, 1994. View at Publisher · View at Google Scholar · View at Scopus
  50. L. Cai, N. Tuncer, and M. Martcheva, “How does within-host dynamics affect population-level dynamics? insights from an immuno-epidemiological model of malaria,” Mathematical Methods in the Applied Sciences, vol. 40, no. 18, pp. 6424–6450, 2017. View at Publisher · View at Google Scholar · View at Scopus
  51. C. Chiyaka, W. Garira, and S. Dube, “Modelling immune response and drug therapy in human malaria infection,” Computational and Mathematical Methods in Medicine, vol. 9, no. 2, pp. 143–163, 2008. View at Publisher · View at Google Scholar · View at Scopus
  52. S. Pilyugin and R. Antia, “Modeling immune responses with handling time,” Bulletin of Mathematical Biology, vol. 62, no. 5, pp. 869–890, 2000. View at Publisher · View at Google Scholar · View at Scopus
  53. M. A. Selemani, L. S. Luboobi, and Y. Nkansah-Gyekye, “The in-human host and in-mosquito dynamics of malaria parasites with immune responses,” New Trends in Mathematical Sciences, vol. 5, no. 3, pp. 182–207, 2017. View at Publisher · View at Google Scholar
  54. J. C. de Roode, R. Culleton, A. S. Bell, and A. F. Read, “Competitive release of drug resistance following drug treatment of mixed plasmodium chabaudi infections,” Malaria Journal, vol. 3, no. 1, 2004. View at Publisher · View at Google Scholar · View at Scopus
  55. R. Hayward, K. J. Saliba, and K. Kirk, “pfmdr1 mutations associated with chloroquine resistance incur a fitness cost in plasmodium falciparum,” Molecular Microbiology, vol. 55, no. 4, pp. 1285–1295, 2005. View at Publisher · View at Google Scholar · View at Scopus
  56. D. L. Doolan, C. Dobano, and J. K. Baird, “Acquired immunity to malaria,” Clinical Microbiology Reviews, vol. 22, no. 1, pp. 13–36, 2009. View at Publisher · View at Google Scholar · View at Scopus
  57. P. Liehl, P. Meireles, I. S. Albuquerque et al., “Innate immunity induced by plasmodium liver infection inhibits malaria reinfections,” Infection and Immunity, vol. 83, no. 3, pp. 1172–1180, 2015. View at Publisher · View at Google Scholar · View at Scopus
  58. N. Villarino and N. W. Schmidt, “CD8+ T cell responses to plasmodium and intracellular parasites,” Current Immunology Reviews, vol. 9, no. 3, pp. 169–178, 2013. View at Google Scholar
  59. T. O. Orwa, R. W. Mbogo, and L. S. Luboobi, “Mathematical model for hepatocytic-erythrocytic dynamics of malaria,” International Journal of Mathematics and Mathematical Sciences, vol. 2018, Article ID 7019868, 18 pages, 2018. View at Publisher · View at Google Scholar · View at Scopus
  60. T. O. Orwa, R. W. Mbogo, and L. S. Luboobi, “Mathematical model for the in-host malaria dynamics subject to malaria vaccines,” Letters in Biomathematics, vol. 5, no. 1, pp. 222–251, 2018. View at Publisher · View at Google Scholar · View at Scopus
  61. J. K. Hale, Ordinary Differential Equations, John Wiley & Sons, New York, NY, USA, 1969.
  62. P. van den Driessche and J. Watmough, “Reproduction numbers and sub-threshold endemic equilibria for compartmental models of disease transmission,” Mathematical Biosciences, vol. 180, no. 1-2, pp. 29–48, 2002. View at Publisher · View at Google Scholar · View at Scopus
  63. K. S. Vannice, G. V. Brown, B. D. Akanmori, and V. S. Moorthy, “MALVAC 2012 scientific forum: accelerating development of second-generation malaria vaccines,” Malaria Journal, vol. 11, no. 1, p. 372, 2012. View at Publisher · View at Google Scholar · View at Scopus
  64. L. J. Allen, Introduction to Mathematical Biology, Pearson/Prentice Hall, Upper Saddle River, NJ, USA, 2007.
  65. J. C. Kamgang and G. Sallet, “Global asymptotic stability for the disease free equilibrium for epidemiological models,” Comptes Rendus Mathematique, vol. 341, no. 7, pp. 433–438, 2005. View at Publisher · View at Google Scholar · View at Scopus
  66. X. Wang, “A simple proof of Descartes’s rule of signs,” The American Mathematical Monthly, vol. 111, no. 6, pp. 525-526, 2004. View at Publisher · View at Google Scholar · View at Scopus
  67. L. Esteva and C. Vargas, “Influence of vertical and mechanical transmission on the dynamics of dengue disease,” Mathematical Biosciences, vol. 167, no. 1, pp. 51–64, 2000. View at Publisher · View at Google Scholar · View at Scopus
  68. M. Krasnoselskii, Positive Solutions of Operator Equations, Noordhoff, Groningen, Netherlands, 1964.
  69. Y. Li, S. Ruan, and D. Xiao, “The within-host dynamics of malaria infection with immune response,” Mathematical Biosciences and Engineering, vol. 8, no. 4, pp. 999–1018, 2011. View at Publisher · View at Google Scholar · View at Scopus
  70. C. Chiyaka, “Using mathematics to understand malaria infection during erythrocytic stages,” Zimbabwe Journal of Science and Technology, vol. 5, pp. 1–11, 2010. View at Google Scholar
  71. C. Colijn and T. Cohen, “How competition governs whether moderate or aggressive treatment minimizes antibiotic resistance,” Elife, vol. 4, 2015. View at Publisher · View at Google Scholar · View at Scopus
  72. R. M. Anderson, C. A. Facer, and D. Rollinson, “Research developments in the study of parasitic infections,” Parasitology, vol. 99, no. S1, p. S1, 1989. View at Publisher · View at Google Scholar · View at Scopus
  73. A. Mohammed, A. Ndaro, A. Kalinga et al., “Trends in chloroquine resistance marker, Pfcrt-K76T mutation ten years after chloroquine withdrawal in Tanzania,” Malaria Journal, vol. 12, no. 1, p. 415, 2013. View at Publisher · View at Google Scholar · View at Scopus
  74. A. Ofosu-Okyere, M. J. Mackinnon, M. P. K. Sowa et al., “Novel plasmodium falciparum clones and rising clone multiplicities are associated with the increase in malaria morbidity in ghanaian children during the transition into the high transmission season,” Parasitology, vol. 123, no. 2, pp. 113–123, 2001. View at Publisher · View at Google Scholar · View at Scopus
  75. B. Hellriegel, “Modelling the immune response to malaria with ecological concepts: short-term behaviour against long-term equilibrium,” Proceedings of the Royal Society of London Series B, vol. 250, no. 1329, pp. 249–256, 1992. View at Google Scholar
  76. A. M. Niger and A. B. Gumel, “Immune response and imperfect vaccine in malaria dynamics,” Mathematical Population Studies, vol. 18, no. 2, pp. 55–86, 2011. View at Publisher · View at Google Scholar · View at Scopus
  77. E. A. Ashley, M. Dhorda, R. M. Fairhurst et al., “Spread of artemisinin resistance in plasmodium falciparum malaria,” New England Journal of Medicine, vol. 371, no. 5, pp. 411–423, 2014. View at Publisher · View at Google Scholar · View at Scopus
  78. D. Lane, “Online statistics education: a multimedia course of study,” in Proceedings of the EdMedia: World Conference on Educational Media and Technology, pp. 1317–1320, Association for the Advancement of Computing in Education (AACE), Rice Univesity, Houston, TX, USA, 2003.
  79. H. Gelband, C. B. Panosian, K. J. Arrow et al., Saving Lives, Buying Time: Economics of Malaria Drugs in An Age of Resistance, National Academies Press, Washington, DC, USA, 2004.
  80. H. A. Babiker, I. M. Hastings, and G. Swedberg, “Impaired fitness of drug-resistant malaria parasites: evidence and implication on drug-deployment policies,” Expert Review of Anti-Infective Therapy, vol. 7, no. 5, pp. 581–593, 2009. View at Publisher · View at Google Scholar · View at Scopus
  81. B. Teun, O. Lucy, S. Seif et al., “Revisiting the circulation time of plasmodium falciparum gametocytes: molecular detection methods to estimate the duration of gametocyte carriage and the effect of gametocytocidal drugs,” Malaria Journal, vol. 2, no. 9, p. 136, 2010. View at Google Scholar
  82. J. C. de Roode, M. E. H. Helinski, M. A. Anwar, and A. F. Read, “Dynamics of multiple infection and within—host competition in genetically diverse malaria infections,” American Naturalist, vol. 166, no. 5, pp. 531–542, 2005. View at Publisher · View at Google Scholar · View at Scopus
  83. J. A. N. Filipe, E. M. Riley, C. J. Drakeley, C. J. Sutherland, and A. C. Ghani, “Determination of the processes driving the acquisition of immunity to malaria using a mathematical transmission model,” PLoS Computational Biology, vol. 3, no. 12, p. e255, 2007. View at Publisher · View at Google Scholar · View at Scopus